These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32019282)

  • 1. Philadelphia+ Chronic Myeloid Leukemia with CALR Mutation: A Case Report and Literature Review.
    Yoon SY; Jeong SY; Kim C; Lee MY; Kim J; Kim KH; Lee N; Won JH
    Cancer Res Treat; 2020 Jul; 52(3):987-991. PubMed ID: 32019282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
    Lewandowski K; Gniot M; Wojtaszewska M; Kanduła Z; Becht R; Paczkowska E; Mędraś E; Wasilewska E; Iwoła M
    Int J Lab Hematol; 2018 Jun; 40(3):366-371. PubMed ID: 29508552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations.
    Turakhia SK; Murugesan G; Cotta CV; Theil KS
    J Clin Pathol; 2016 Aug; 69(8):713-9. PubMed ID: 26754830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.
    Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA
    Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical myeloproliferative neoplasm with concurrent BCR-ABL1 fusion and CALR mutation: A case report and literature review.
    Liu C; Hu R; Du Z; Abecasis M; Wang C
    Medicine (Baltimore); 2020 Jan; 99(5):e18811. PubMed ID: 32000382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Blastic Crisis in a Patient with Unusual Primary Myelofibrosis Characteristics; A Case Report.
    Razmara Lak E; Sharifzadeh S; Ramzi M; Mokhtari M; Asadpouri R; Abedi E; Tamaddon G
    Cardiovasc Hematol Agents Med Chem; 2024; 22(2):240-245. PubMed ID: 37317905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing.
    Gardner JA; Peterson JD; Turner SA; Soares BL; Lancor CR; Dos Santos LL; Kaur P; Ornstein DL; Tsongalis GJ; de Abreu FB
    Am J Clin Pathol; 2016 Oct; 146(4):448-55. PubMed ID: 27686171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-deep sequencing mutation analysis of the BCR/ABL1 kinase domain in newly diagnosed chronic myeloid leukemia patients.
    Park H; Kim I; Kim HJ; Shin DY; Lee SY; Kwon OH; Kim DY; Lee KH; Ahn JS; Park J; Sohn SK; Lee JO; Cheong JW; Kim KH; Kim HG; Kim H; Lee YJ; Nam SH; Do YR; Park SG; Park SK; Bae SH; Song HH; Oh D; Jung CW; Park S
    Leuk Res; 2021 Dec; 111():106728. PubMed ID: 34673444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two myeloproliferative diseases in one patient - co-occurence of clones].
    Fekete S; Reichardt J; Kozma A; Kapócs K; Meggyesi N
    Orv Hetil; 2022 Jul; 163(28):1123-1129. PubMed ID: 35895464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetics and genomics in CML and other myeloproliferative neoplasms.
    Kreipe HH; Schlegelberger B
    Best Pract Res Clin Haematol; 2024 Jun; 37(2):101552. PubMed ID: 39098796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myeloproliferative neoplasms with concomitant
    Zanelli M; Fragliasso V; Loscocco GG; Sanguedolce F; Broggi G; Zizzo M; Palicelli A; Ricci S; Ambrogi E; Martino G; Aversa S; Coppa F; Gentile P; Gozzi F; Caltabiano R; Koufopoulos N; Asaturova A; Cimino L; Cavazza A; Orcioni GF; Ascani S
    Front Cell Dev Biol; 2024; 12():1391078. PubMed ID: 38596359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atypical myeloproliferative neoplasm with a small population of Philadelphia chromosome-positive clones in the bone marrow].
    Takai K; Ushiki T; Nikkuni K; Hashidate H; Shibuya H
    Rinsho Ketsueki; 2011 Feb; 52(2):73-7. PubMed ID: 21403427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The co-occurrence of driver mutations in chronic myeloproliferative neoplasms.
    Boddu P; Chihara D; Masarova L; Pemmaraju N; Patel KP; Verstovsek S
    Ann Hematol; 2018 Nov; 97(11):2071-2080. PubMed ID: 29951914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up.
    Saydam G; Haznedaroglu IC; Kaynar L; Yavuz AS; Ali R; Guvenc B; Akay OM; Baslar Z; Ozbek U; Sonmez M; Aydin D; Pehlivan M; Undar B; Dagdas S; Ayyildiz O; Akin G; Dag IM; Ilhan O
    Hematology; 2018 Dec; 23(10):771-777. PubMed ID: 29996726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of clinical and genetic features of CML patients with variant Philadelphia translocations involving chromosome 7: A case series.
    Bayrak AG; Daglar Aday A; Yavuz AS; Nalcaci M; Ozbalak MM; Cefle K; Ozturk S; Palanduz S
    Leuk Res; 2021 Dec; 111():106725. PubMed ID: 34634595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CALR-positive myeloproliferative disorder in a patient with Ph-positive chronic myeloid leukemia in durable treatment-free remission: a case report.
    Dogliotti I; Fava C; Serra A; Gottardi E; Daraio F; Carnuccio F; Giugliano E; Bocchia M; Saglio G; Rege-Cambrin G
    Stem Cell Investig; 2017; 4():57. PubMed ID: 28725653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Treatment of a Patient with Chronic Myelogenous Leukemia with Concurrent Janus Kinase 2 (JAK2) R795S Mutation and Breakpoint Cluster Region-ABL1 (BCR-ABL1) Fusion: A Case Report and Literature Review.
    Yue Y; Wei W; Guo Y; Wang F; Dong W; Liu Y; Lin Y; Cao Y; Gu W
    Am J Case Rep; 2020 Oct; 21():e925151. PubMed ID: 33021971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation.
    Kawano N; Okuda S; Yoshida S; Kugimiya H; Ito M; Horikawa N; Chosa N; Hisakata T; Fukudome T; Sakurai R; Yamashita K; Ueda A; Kanda Y
    Int J Hematol; 2011 Dec; 94(6):561-6. PubMed ID: 22057509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformation sensitive gel electrophoresis for the detection of calreticulin mutations in BCR-ABL1-negative myeloproliferative neoplasms.
    Zakaria NA; Rosle NA; Siti Asmaa MJ; Aziee S; Haiyuni MY; Samat NA; Husin A; Hassan R; Ramli M; Mohamed Yusoff S; Ibrahim IK; Al-Jamal HAN; Johan MF
    Int J Lab Hematol; 2021 Dec; 43(6):1451-1457. PubMed ID: 34125992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.